[1]施 洋,黄丽娟,张明涛,等.基于Logit回归模型分析2型糖尿病患者大血管并发症相关危险因素[J].医学信息,2025,38(03):97-102,137.[doi:10.3969/j.issn.1006-1959.2025.03.018]
　SHI Yang,HUANG Lijuan,ZHANG Mingtao,et al.Risk Factors Related to Macrovascular Complications in Patients with Type 2 Diabetes MellitusBased on Logit Regression Model[J].Journal of Medical Information,2025,38(03):97-102,137.[doi:10.3969/j.issn.1006-1959.2025.03.018]
点击复制

基于Logit回归模型分析2型糖尿病患者大血管并发症相关危险因素()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年03期
页码:
97-102,137
栏目:
论著
出版日期:
2025-02-01

文章信息/Info

Title:
Risk Factors Related to Macrovascular Complications in Patients with Type 2 Diabetes MellitusBased on Logit Regression Model
文章编号:
1006-1959（2025）03-0097-07
作者:
施 洋1; 黄丽娟2; 张明涛2; 乙丰收2; 吴胜利2; 朱玉婧2
克拉玛依市中西医结合医院<市人民医院>药剂科1，内分泌代谢中心2，新疆 克拉玛依 834000
Author(s):
SHI Yang1;  HUANG Lijuan2;  ZHANG Mingtao2;  YI Fengshou2;  WU Shengli2;  ZHU Yujing2
Department of Pharmacy1, Endocrine Metabolic Center2, Karamay Municipal Hospital of Integrated Traditional Chinese and Western Medicine , Karamay 834000, Xinjiang, China
关键词:
2型糖尿病; 大血管并发症; Logit回归; 危险因素
Keywords:
Type 2 diabetes mellitus;  Macrovascular complications;  Logit regression;  Risk factors
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2025.03.018
文献标志码:
A
摘要:
目的 采用Logit回归模型分析2型糖尿病（T2DM）患者大血管并发症的危险因素。方法 筛选2018年1月-2020年12月于克拉玛依市中西医结合医院住院的T2DM患者1574例，对性别、年龄、吸烟、高血脂病史等进行回归分析，评价与T2DM大血管并发症相关5种疾病：冠心病、左心室肥厚、脑血管事件、下肢动脉硬化和颈动脉硬化的关系，总结影响T2DM大血管并发症的危险因素。结果 Logit回归分析结果显示，冠心病与年龄、高血压病程、糖尿病病程、低密度脂蛋白（LDL）、糖化血红蛋白（HBA1c）、糖尿病治疗情况、脂肪肝、高血压治疗情况相关（P＜0.05）；左心室肥厚与高血压病程相关（P＜0.05）；脑血管事件与性别、年龄、高血压病程、糖尿病病程、每月酒精量相关（P＜0.05）；下肢动脉硬化与性别、年龄、糖尿病病程、餐后2 h血糖相关（P＜0.05）；颈动脉硬化与性别、年龄、高血压病程、高血脂病史、收缩压、餐后2 h血糖、甘油三酯、维生素D相关（P＜0.05）。结论 T2DM大血管并发症与多种危险因素相关，控制危险因素，降低并发症发生率，以确保T2DM患者有效提高生存率、改善生活质量、延长生存期。
Abstract:
Objective To analyze the risk factors of macrovascular complications in patients with type 2 diabetes mellitus (T2DM) by Logit regression model. Methods A total of 1574 patients with T2 DM who were hospitalized in Karamay Municipal Hospital of Integrated Traditional Chinese and Western Medicine from January 2018 to December 2020 were screened. Regression analysis was performed on gender, age, smoking, and history of hyperlipidemia. The relationship between five diseases related to T2DM macrovascular complications: coronary heart disease, left ventricular hypertrophy, cerebrovascular events, lower extremity arteriosclerosis, and carotid atherosclerosis was evaluated, and the risk factors affecting T2DM macrovascular complications were summarized. Results The results of Logit regression analysis showed that coronary heart disease was related to age, course of hypertension, course of diabetes, low density lipoprotein (LDL), glycosylated hemoglobin (HBA1c), treatment of diabetes, fatty liver and treatment of hypertension (P<0.05). Left ventricular hypertrophy was associated with the course of hypertension (P<0.05). Cerebrovascular events were related to gender, age, duration of hypertension, duration of diabetes, and monthly alcohol consumption (P<0.05). Lower extremity arteriosclerosis was associated with gender, age, duration of diabetes, and 2 h postprandial blood glucose (P<0.05). Carotid atherosclerosis was correlated with gender, age, course of hypertension, history of hyperlipidemia, systolic blood pressure, 2 h postprandial blood glucose, triglyceride and vitamin D (P<0.05). Conclusion T2DM macrovascular complications are related to a variety of risk factors. Controlling risk factors and reducing the incidence of complications can ensure that T2DM patients can effectively improve survival rate, improve quality of life and prolong the survival time.

参考文献/References:

[1]陈灏珠,钟南山,陆再英.内科学[M].9版.北京:人民卫生出版社,2018:725-728.[2]万仁辉,鲁瑾.2型糖尿病大血管并发症的影响因素[J].第二军医大学学报,2020,41(1):75-80.[3]王中群.重视糖尿病大血管并发症的发病、机制、评估与防治研究[J].中南医学科学杂志,2022,50(1):1-6.[4]郭艺芳.糖尿病患者的心血管病和危险因素管理[J].中国心血管杂志,2023,28(3):201-204.[5]王静龙,梁小筠.定性数据统计分析[M].北京:中国统计出版社,2010.[6]施洋,朱玉婧,谢爱霞,等.二甲双胍对2型糖尿病患者miRNA表达的影响及作用靶点预测研究[J].中华内分泌代谢杂志,2021,37(9):782-788.[7]Mehravar F,Mansournia MA,Holakouie-Naieni K,et al.Associations between diabetes self-management and microvascular complications in patients with type 2 diabetes[J].Epidemiol Health,2016,38:e2016004.[8]Morgan CL,Peters JR,Currie CJ.The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK[J].Diabet Med,2010,27(6):673-678.[9]王臣廷,安向莲,吕翠君,等.2型糖尿病病人并发大血管病变的危险因素分析[J].中西医结合心脑血管病杂志,2023,21(19):3607-3609.[10]孙文宇,乔晶,孟敏敏,等.甘油三酯葡萄糖指数与2型糖尿病胰岛素抵抗及血管并发症的相关性[J].临床内科杂志,2023,40(10):681-685.[11]Toyota T,Furukawa Y,Ehara N,et al.Sex-based differences in clinical practice and outcomes for Japanese patients with acute myocardial infarction undergoing primary percutaneous coronary intervention[J].Circ J,2013,77(6):1508-1517.[12]Benjamin EJ,Muntner P,Alonso A,et al.Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association[J].Circulation,2019,139(10):e56-e528.[13]Chakrabarti S,Morton JS,Davidge ST.Mechanisms of estrogen effects on the endothelium: an overview[J].Can J Cardiol,2014,30(7):705-712.[14]Pan HC,Chou KM,Lee CC,et al.Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients[J].Atherosclerosis,2018,276:83-90.[15]Wada H,Miyauchi K,Daida H.Gender differences in the clinical features and outcomes of patients with coronary artery disease[J].Expert Rev Cardiovasc Ther,2019,17(2):127-133.[16]Boehme AK,Esenwa C,Elkind MS.Stroke Risk Factors, Genetics, and Prevention[J].Circ Res,2017,120(3):472-495.[17]De Meyer T,Nawrot T,Bekaert S,et al.Telomere Length as Cardiovascular Aging Biomarker: JACC Review Topic of the Week[J].J Am Coll Cardiol,2018,72(7):805-813.[18]Yoo HJ,Hwang SY,Hong HC,et al.Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes[J].Cardiovasc Diabetol,2011,10:103.[19]Berkelmans GFN,Gudbj?觟rnsdottir S,Visseren FLJ,et al.Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus[J].Eur Heart J,2019,40(34):2899-2906.[20]Rawshani A,Rawshani A,Franzén S,et al.Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes[J].N Engl J Med,2018,379(7):633-644.[21]Araki E,Goto A,Kondo T,et al.Japanese Clinical Practice Guideline for Diabetes 2019[J].Diabetol Int,2020,11(3):165-223.[22]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(03):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(03):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(03):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(03):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
　LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(03):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[7]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
　DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(03):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
[8]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
　LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(03):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[9]刘小红.长效胰岛素联合口服降糖药治疗2型糖尿病的 疗效与安全性评价[J].医学信息,2018,31(18):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
　LIU Xiao-hong.Efficacy and Safety of Long Acting Insulin Combined with Oral Hypoglycemic Agents in Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(03):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
[10]鲍 哲,杨升伟,柯赛赛,等.益生元对2型糖尿病患者糖脂代谢的影响[J].医学信息,2018,31(18):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]
　BAO Zhe,YANG Sheng-wei,KE Sai-sai,et al.Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus[J].Journal of Medical Information,2018,31(03):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]

更新日期/Last Update: 1900-01-01